← SynDRA
CALCIFEDIOL ANHYDROUS
SynDRA canonical compound SYN0003316 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | VDR |
|---|
| Mechanism of action | vitamin D receptor agonist |
|---|
| Indication | hyperparathyroidism |
|---|
| Disease area | endocrinology |
|---|
All known targets
Mechanisms of action (all sources)
- VDR AGONIST
- Vitamin D receptor agonist
- VDR ANTAGONIST
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- CTSL
- GMNN
- HDAC6
- SCAP
- TDP1
- USP1
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Drug classes
- Bone Density Conservation Agents
- Micronutrients
- Vitamins
ATC classes
- A11C · VITAMIN A AND D, INCL. COMBINATIONS OF THE TWO
- H05B · ANTI-PARATHYROID AGENTS
Cross-references
Synonyms
- CALDEROL
- RAYALDEE
- Rayaldee
- calcifediol
- calcidiol
- calderol
- 25-hydroxycholecalciferol (calcifediol)
- Calcifediol, anhydrous
- Calcifediol,anhydrous
- Calcidiol
- Calcifediolum
- Calcifidiol
- Delakmin
- VDY
- BML2-E02
- Calcifediolum [INN-Latin]
- Ro 8-8892
- U-32070E
- (3beta,5Z,7E)-9,10-secocholesta-5,7,10(19)-triene-3,25-diol
- 25(OH)D3
- 25-(OH)Vitamin D3
- 25-Hydroxycholecalciferol
- 25-Hydroxycholecalciferol (Calcifediol)
- 25-Hydroxycholescalciferol
- 25-Hydroxyvitamin D
- 25-Hydroxyvitamin D3 monohydrate
- 25-hydroxyvitamin D3
- 5,6-cis-25-Hydroxyvitamin D3
- 5,6-trans-25-Hydroxycholescalciferol
- 5,6-trans-9,10-Seco-5,7,10(19)-cholestatrien-3beta,25-diol
- 9,10-Secocholesta-5,7,10(19)-triene-3beta,25-diol
- Hidroferol
- Didrogyl
- T0WXW8F54E
- Calcifediol monohydrate
- calcifediol (usp monograph)
- Calcifediol hydrate
- CALCIFEDIOL, ANHYDROUS
- U-32,070E
Look up CALCIFEDIOL ANHYDROUS in the interactive SynDRA portal →